CDC Resorting to “Politically Motivated False Science”
SEP 25, 2018 —
News Release: Dr. Sin Hang Lee Accuses CDC of Resorting to Politically Motivated False Science to Cover Up Its Failure to Promote More Exacting Test for Lyme Disease
To the Tick-Borne Disease Working Group,
Before you read the following press release I would like to point out that Patient #45 from Table 2 of the attached CDC document titled, “Reply to Response to Motion to Dismiss” (page 26) had a bulls-eye rash and a single positive Western blot Band 41 which as you know is the flagellar antigen of Borrelia burgdorferi.
Patient #45 has a case of early Lyme confirmed by the bulls-eye rash but hadn’t yet produced a full set of antibodies to the infection. Dr. Lee’s 16S rRNA gene sequencing was able to accurately detect early infection before antibody production.
The CDC claims the following:
“ with respect to pretreatment patients, he (Dr. Sin Hang Lee) reported B. burgdorferi in a patient whose antibody testing failed to indicate the presence of the disease at all (patient 45). Attachment I at 4287 and 4292. Therefore, Dr. Lee’s tests were not accurate.”
For the record, you will find the following statement from the CDC website:
Diagnosis, Testing, and Treatment
As with serologic tests for other infectious diseases, the accuracy of the test depends upon the stage of disease. During the first few weeks of infection, such as when a patient has an erythema migrans rash, the test is expected to be negative.
The CDC is responsible for the current Lyme disease crisis where patients cannot obtain a timely diagnosis through accurate early detection.
This perpetuated outdated dogma of using a restricted pattern of antibody tests for disease definition is now on record disclosing the hidden agenda of the bureaucrats in charge of the Lyme disease policy.
MILFORD MOLECULAR DIAGNOSTICS
2044 Bridgeport Avenue
Milford, CT 06460
September 25, 2018
Media Contact: Kevin Moore
FOR IMMEDIATE RELEASE
In Unprecedented CDC lawsuit, Dr. Sin Hang Lee Accuses CDC of Resorting to Politically Motivated False Science to Cover Up Its Failure to Promote More Exacting Test for Lyme Disease
Milford, Conn. – Dr. Sin Hang Lee, the Connecticut based pathologist who, in May, filed an unprecedented $57.1 million Lyme disease related lawsuit against the United States Centers for Disease Control and Prevention (CDC), charged the CDC in a legal filing* this week of employing false, pseudo-scientific theories in order to justify its own anti-consumer actions aimed at perpetuating Lyme disease testing by a flawed technology previously endorsed by the CDC. It is also believed that certain current and former CDC representatives receive personal financial gains (royalties) as a result of their having worked on the approval and promotion/CDC endorsement of a Lyme disease serology test.
According to Dr. Lee, the truth behind the CDC’s inexplicable retreat from supporting a cutting-edge test capable of diagnosing Lyme disease infections with 100% accuracy, came to the surface in the CDC’s lawsuit-related recent filing in the U. S. Court of Federal Claims. For the purpose of suppressing direct detection tests to diagnose early Lyme disease infections, the CDC’s lawyers wrote,
“with respect to pretreatment patients, he (Dr. Sin Hang Lee) reported B. burgdorferi in a patient whose antibody testing failed to indicate the presence of the disease at all (patient 45). Attachment I at 4287 and 4292. Therefore, Dr. Lee’s tests were not accurate.”
Dr. Lee informed the Court through his legal counsel,
“Using Lyme disease serology test results to overrule 16S ribosomal RNA gene sequencing diagnosis of Lyme borreliosis is to practice Lysenkoism in disguise.”
It is serious when the CDC allows its policies to be made on the basis of bogus science, said Dr. Lee.
Dr. Sin Hang Lee, a Connecticut pathologist and the plaintiff in the $57.1 million lawsuit against the CDC, said Lyme disease is actually a chronic tick-borne borrelia infection or its sequelae because this bacterial infection has not been diagnosed correctly at the early stage for timely appropriate treatment. The world’s scientific literature of medicine all agrees that 16S rRNA DNA sequencing of bacterial genes in patient specimens is a tool to reach irrefutable diagnosis of bacterial infections, including those due to Borrelia, even if antibodies to the bacteria in the patient are not measurable.
When a government authority, like the CDC, insists upon using a negative antibody testing result to overrule the 16S rRNA gene sequencing diagnosis of Borrelia burgdorferi infection in official federal court documents, this is concrete evidence that the CDC has resorted to Lysenkoism to perpetuate Lyme disease in the United States, said Dr. Sin Hang Lee through his lawyer*.
Lysenkoism once prevailed in the Soviet Union under Stalin when bogus science was used to suppress true biological and medical sciences and to punish the scientists and medical doctors who did not follow the Party Line. Since the CDC has now, for the first time, officially narrowed the case definition of Lyme disease in a Federal Court case as an illness to be diagnosed by testing the antibodies against a particular strain of Borrelia burgdorferi to the exclusion of all other direct detection diagnostics, including Sanger sequencing, this Party Line must be challenged by evidence-based science in the public eye as well as in Court, said Dr. Lee.
* See document, called Sur-Reply filed on September 20, 2018 at the U.S. Federal Court of Claims in response to the CDC statements previously submitted to the Court on August 27, 2018.
1. Lee – Sur-Reply re Motion to Dismiss 2018-09-20
2. Lee – Reply to Response to Motion to Dismiss
Lyme Disease Frequently Asked Questions (FAQ) | Lyme Disease | CDC
Information on Lyme disease. Provided by the U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/lyme/faq/index.html